Recent developments in U.S. case law may dramatically affect an innovator's ability to protect technologies that competitors may seek to copy and divide among multiple parties and/or in multiple countries. An international panel of experienced IP professionals with backgrounds in biopharma and devices will discuss challenges and solutions for protecting and enforcing patents in the U.S. and overseas, including the types of biotechnology innovations for which multi-party and multi-jurisdiction enforcement issues are likely to arise and the state of the law concerning these issues. Panelists will also discuss the potential impact on the enforcement of biotechnology IP, protection of innovations and the impact of recent legislation (e.g., the America Invents Act).

Learning Objectives:

  • Inform legal and business pros on current patent law concerning multi-party and cross-border issues
  • Discuss examples of biotech inventions that these issues stand to impact
  • Explore approaches for protecting innovations, patent enforcement, and impact on business decisions

Ability Level: Advanced

Session ID: 1893

myBIO Chatter

Speakers (3)

contact_9675 Bernd Allekotte Partner Gr√ľnecker
contact_9674 Paul Cantrell Assistant General Patent Counsel Eli Lilly and Company
contact_9676 Michael Kirschner Assistant General Counsel Baxter International Inc.

Moderators (1)

contact_9414 Matthew Nielsen Partner Marshall, Gerstein & Borun LLP